Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries. - Wikidata - awgldk - TriplyDB

Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.

Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.

http://www.wikidata.org/entity/Q42882636

about

Calcitonin gene-related peptide: physiology and pathophysiology Endosomal proteolysis regulates calcitonin gene-related peptide responses in mesenteric arteries Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.Therapeutic antibodies against CGRP or its receptor Dural administration of inflammatory soup or Complete Freund's Adjuvant induces activation and inflammatory response in the rat trigeminal ganglion.Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca2+ levels in the perfused and non-perfused isolated rat middle cerebral artery.CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?Tracing neural connections to pain pathways with relevance to primary headaches.Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies.CGRP antagonists and antibodies for the treatment of migraine.The Journey to Establish CGRP as a Migraine Target: A Retrospective View.New treatments for headache.Chronic migraine treatment: from OnabotulinumtoxinA onwards.CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment.Trigeminal TRPs and the scent of pain.Triptans and CGRP blockade - impact on the cranial vasculature.Differential localization and characterization of functional calcitonin gene-related peptide receptors in human subcutaneous arteries.CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior.Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.CGRP and its receptors.A randomized, placebo-controlled study of the effects of telcagepant on exercise time in patients with stable angina.Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study.Calcitonin gene-related powerpeptide and its puzzling receptor.Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries Vascular Contributions to Migraine: Time to Revisit?

P2860

Q28249298-F4C31AA8-3C00-427C-AFC8-827F24E90E0C Q28577195-597E85CF-6684-4BD7-BB8A-B0708EC48E21 Q33778781-465EA3BC-CE0B-49A6-91B5-3B6BE619B69A Q35684794-FD5268CA-1711-4C76-8DDC-2A4E3E3743FC Q36017049-7EADF6EF-89DD-48A5-9950-5DE172D399C8 Q36385789-60D2D1F4-E40F-4BA9-95BB-C8A7BA26EB2A Q37337815-EF5A6E83-E824-48F8-9E89-AAADE17BFF1A Q37845008-19645AB0-9BBE-41EA-B638-C8BFE94E72A7 Q38130336-91D5047E-A1C9-4F34-AE78-FC22129B5B9D Q38248953-00951A74-8619-43E1-B24E-00AF199AB727 Q38561443-594A9185-5A2F-4F8D-A519-943D6C3C9656 Q38773593-08BD44A7-C112-45BA-93F2-C3ADE779D71E Q38866988-9194BF24-A5D8-4F2E-9A69-6514548F28CA Q39193269-E8F41B81-7ABE-41EA-A10F-05E41BCFC83E Q41930635-ED01B90D-9151-4CF7-A07E-51790EAF3E6D Q42706186-260343C6-FF61-4389-B7BB-A3FAA1C1A31C Q46960593-602BD604-D2AD-4508-9AC6-255353A760BF Q47710418-006C555A-A3DB-4317-B6FC-D6E6C5EC0BD4 Q47819343-B86587AB-1FC4-4DAC-8D78-292A8F002E81 Q48198655-B682552E-11A1-4612-AC11-99F7A49ED32B Q48745119-F23152E0-758F-4FE2-BACA-9EBC00C779E9 Q48859221-014F6B88-A17A-4D4E-AF5C-89DE9E88B6B6 Q49090569-1EDC2E8C-74EF-4EFF-BBCF-923F55BD9930 Q57197707-2A8CBFF3-C896-4DDF-874E-691BE14928A3 Q58783494-4AE349E6-7BB9-4760-94C9-DF6ED51327C3 Q58801458-9733FF78-023F-4181-8C72-B6756DFFD1D0

P2860

Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.

http://www.wikidata.org/entity/Q42882636

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Effect of the calcitonin gene- ...... ant in human cranial arteries.

@en

Effect of the calcitonin gene-related peptide

@nl

type

label

Effect of the calcitonin gene- ...... ant in human cranial arteries.

@en

Effect of the calcitonin gene-related peptide

@nl

prefLabel

Effect of the calcitonin gene- ...... ant in human cranial arteries.

@en

Effect of the calcitonin gene-related peptide

@nl

P1433

Q42882636-D7691AB9-1763-42E7-B541-D3012958E043

P1476

Q42882636-2E51889B-E48F-4C2F-AEA4-E64EEACD39EA

P2093

Q42882636-0CD2F80C-B6FD-47C0-AAD7-CBE0CAB6A80A

Q42882636-52DB714F-58F3-403B-8CC5-88581208941D

Q42882636-73FA8F04-7401-4BDB-B90B-0E67BEAC42C9

Q42882636-89D9DF11-875E-47C8-8886-F35734DBC062

Q42882636-AA7F0878-FC01-4508-BCB1-BEF57DB57AC5

Q42882636-D4A06A38-17BA-450C-A573-7AA9CB3624AB

Q42882636-D907DD12-DDB6-4E7C-8AE8-232CD1EDAE10

Q42882636-DE0BE4DC-8117-4009-880F-6BA52844B8F4

P2860

Q42882636-0BEE27D8-E9A4-4DF2-90D6-1EAD56F9FD21

Q42882636-30D77E8D-D146-4991-8D2F-A9D0E8A9C171

Q42882636-38308509-1087-4EFB-AEAD-EDB1410F7EEE

Q42882636-3D489048-6A49-4812-A5ED-CE49184B4DAC

Q42882636-5BCD8891-2C4D-4AD3-814E-19E778002D31

Q42882636-5D592625-68A5-48B6-A1C8-EAA695FA3FF5

Q42882636-6B86DCA1-6C73-4AC2-B5D8-3BA93AD85616

Q42882636-71625246-1CD1-4391-B0B1-42C732D58C1D

Q42882636-7D6684E4-F05A-424D-A041-217A03158E28

Q42882636-7E6EBF30-4132-4EBE-8415-1FCA102844EF

P304

Q42882636-E57CE7A2-3219-488E-AC43-4B309A1FBEFA

P31

Q42882636-430AE173-DDBB-45A7-AAB4-0FCA65C2FD35

P356

Q42882636-4E9636DE-D60A-432A-BE7C-81798986B439

P407

Q42882636-0657F1CA-1D1E-416D-9EAC-A61A0BC6CEF5

P433

Q42882636-576869F4-368C-4131-846D-24D7402DD6D9

P478

Q42882636-C3DBBB37-996D-47B5-AFA9-DE97D97DD322

P50

Q42882636-44486BC9-00ED-4C37-8CDF-9014069B26E6

P577

Q42882636-729C368C-4E37-47D1-AF28-1B0D0C6CBE2F

P698

Q42882636-C69CF263-8983-43D5-84AA-A7FAE2FFBD0A

P356

0333102410362122

P1433

P1476

Effect of the calcitonin gene- ...... ant in human cranial arteries.

@en

P2093

A H Jan Danser

http://www.w3.org/2001/XMLSchema#string

Antoinette MaassenVanDenBrink

http://www.w3.org/2001/XMLSchema#string

Clemens M F Dirven

http://www.w3.org/2001/XMLSchema#string

Elisabeth Nilsson

http://www.w3.org/2001/XMLSchema#string

Hans Säveland

http://www.w3.org/2001/XMLSchema#string

Kayi Y Chan

http://www.w3.org/2001/XMLSchema#string

René de Vries

http://www.w3.org/2001/XMLSchema#string

Sajedeh Eftekhari

http://www.w3.org/2001/XMLSchema#string

P2860

BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP(8-37)

Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

Some quantitative uses of drug antagonists

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine.

Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

P304

1233-1240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0333102410362122

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20855369

http://www.w3.org/2001/XMLSchema#string